Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Akari Therapeutics PLC (AKTX) had Weighted-Average Shares Outstanding (Diluted) of 27.29M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-3.71M |
|
-- |
|
-- |
|
$3.52M |
|
$-3.52M |
|
$-0.18M |
|
$-3.71M |
|
$-3.71M |
|
$-3.71M |
|
$-3.71M |
|
$-3.71M |
|
$-3.71M |
|
$-3.52M |
|
$-3.52M |
|
27.29M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
27.29M |
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$3.35M |
|
-- |
|
$47.61M |
|
$50.96M |
|
$20.91M |
|
-- |
|
$8.31M |
|
$29.21M |
|
$21.75M |
|
$-25.86M |
|
$21.75M |
|
28.88M |
|
| Cash Flow Statement Financials | |
$-2.15M |
|
-- |
|
$2.13M |
|
$2.66M |
|
$2.64M |
|
$-0.02M |
|
$1.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.16 |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.15M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.04% |
|
14.32% |
|
-7.27% |
|
-17.04% |
|
$0.75 |
|
$-0.08 |
|
$-0.08 |
|